Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 12/20 | 0.67 |
| ▸ | MTNR1B | P49286 | 11/20 | 0.67 |
| ▸ | NQO2 | P16083 | 5/20 | 0.67 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | HTR2C | P28335 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1289440 | 1.00 | MTNR1A (0.67) | MTNR1AMTNR1BNQO2ABCB1MAPT | |
| SCHEMBL1289442 | 1.00 | MTNR1A (0.67) | MTNR1AMTNR1BNQO2ABCB1MAPT | |
| SCHEMBL4689417 | 0.93 | MTNR1A (0.78) | MTNR1AMTNR1BNQO2NPC1RAB9A | |
| SCHEMBL4689415 | 0.93 | MTNR1A (0.78) | MTNR1AMTNR1BNQO2NPC1RAB9A | |
| SCHEMBL4689419 | 0.93 | MTNR1A (0.78) | MTNR1AMTNR1BNQO2NPC1RAB9A | |
| SCHEMBL7956587 | 0.86 | MTNR1A (0.65) | MTNR1AMTNR1BNQO2ABCB1MAPT | |
| SCHEMBL7956592 | 0.86 | MTNR1A (0.65) | MTNR1AMTNR1BNQO2ABCB1MAPT | |
| SCHEMBL7952088 | 0.86 | MTNR1A (0.62) | MTNR1AMTNR1BNQO2ABCB1MAPT | |
| SCHEMBL7951430 | 0.86 | MTNR1B (0.62) | MTNR1AMTNR1BNQO2ABCB1MAPT | |
| SCHEMBL7956590 | 0.86 | MTNR1A (0.65) | MTNR1AMTNR1BNQO2ABCB1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012046253-A2 | PROCESS FOR THE PREPARATION OF N-[2- (7-METHOXY-L-NAPHTHYL) ETHYL] ACETAMIDE AND ITS NOVEL CRYSTALLINE FORMS | MSN LABORATORIES LIMITED (IN) | 2012-04-12 | — | — | WO | claimed |
| WO-2015000555-A2 | A NOVEL PROCESS FOR THE PREPARATION OF TETRALIN AND NAPHTHALENE DERIVATIVES | PHARMATHEN S.A. (GR) | 2015-01-08 | — | — | WO | disclosed |
| WO-2012046253-A2 | PROCESS FOR THE PREPARATION OF N-[2- (7-METHOXY-L-NAPHTHYL) ETHYL] ACETAMIDE AND ITS NOVEL CRYSTALLINE FORMS | MSN LABORATORIES LIMITED (IN) | 2012-04-12 | — | — | WO | disclosed |
| US-6235789-B1 | GLANDULAR DISORDERS; SLEEP DISORDERS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2001-05-22 | — | — | US | disclosed |
| EP-0781271-B1 | BENZOCYCLOALKENE COMPOUNDS, THEIR PRODUCTION AND USE | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2000-06-07 | — | — | EP | disclosed |
| EP-0781271-A1 | BENZOCYCLOALKENE COMPOUNDS, THEIR PRODUCTION AND USE | Takeda Chemical Industries, Ltd. (JP) | 1997-07-02 | — | — | EP | disclosed |
| WO-1996008466-A1 | BENZOCYCLOALKENE COMPOUNDS, THEIR PRODUCTION AND USE | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1996-03-21 | — | — | WO | disclosed |